The final, formatted version of the article will be published soon.
REVIEW article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 |
doi: 10.3389/fphar.2025.1526359
Ehretia genus: A comprehensive review of its botany, ethnomedicinal values, phytochemistry, pharmacology, toxicology and clinical studies
Provisionally accepted- 1 Hunan Academy of Chinese Medicine, Changsha, China
- 2 Hunan University of Chinese Medicine, Changsha, China
- 3 IFTM University, Moradabad, India
- 4 Forestry Bureau of Hengnan County, Hengyang, China
Background: The Ehretia genus, comprising 66 species in the Boraginaceae family, has a history of ethnomedicinal use for various ailments. This review focuses on the botany, traditional uses, phytochemistry, pharmacology, toxicology, clinical studies, cultivation, and commercial potential of the Ehretia genus, with the goal of enhancing current research and applications.Methods: Literatures related to Ehretia species were compiled using keywords such as “Ehretia”, “traditional use”, “chemical constituents”, and “bioactivity” from scientific databases, including "China Knowledge Resource Integrated Databases (CNKI)", "Flora of China", "Google Scholar", "Hunan Library", "Plants of the World Online", and “Web of Science” and so on.Results: From 1980 to August 2024, only 101 compounds have been identified within this genus, primarily consisting of flavonoids, phenylpropanoids, phenolics, benzoquinones, triterpenoids, and fatty acids, with phenylpropanoids being the main components. Extracts and compounds from Ehretia species exhibited various bioactivities, including antioxidant, hepatoprotective, analgesic, anti-inflammatory, antibacterial, and anticancer effects, etc.Conclusion: Research on the Ehretia genus is limited, with many species remaining underexamined in terms of phytochemistry and pharmacology. Few active compounds have been isolated and assessed for biological activities, and there is a lack of investigation into their mechanisms of action. Despite its documented uses, Ehretia species remains less explored scientifically than other Boraginaceae genera, presenting significant research opportunities. Further comprehensive studies are necessary to deepen our understanding of this diverse genus and validate its therapeutic potential.
Keywords: Ehretia genus, Traditional uses, phytochemistry, Pharmacology, clinical studies
Received: 11 Nov 2024; Accepted: 03 Feb 2025.
Copyright: © 2025 Jiang, Wang, Kaur, Jiang, Cai, Luo, Li, Wang, Wan and Peng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Mengyun Wang, Hunan University of Chinese Medicine, Changsha, China
Jiangyi Luo, Hunan University of Chinese Medicine, Changsha, China
Minxi Li, Hunan Academy of Chinese Medicine, Changsha, China
Hongxing Wang, Forestry Bureau of Hengnan County, Hengyang, China
Dan Wan, Hunan Academy of Chinese Medicine, Changsha, China
Yanmei Peng, Hunan Academy of Chinese Medicine, Changsha, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.